262 related articles for article (PubMed ID: 28898877)
1. Identification of Small and Non-Small Cell Lung Cancer Markers in Peripheral Blood Using Cytokinesis-Blocked Micronucleus and Spectral Karyotyping Assays.
El-Zein RA; Abdel-Rahman S; Santee KJ; Yu R; Shete S
Cytogenet Genome Res; 2017; 152(3):122-131. PubMed ID: 28898877
[TBL] [Abstract][Full Text] [Related]
2. Cytokinesis-blocked micronucleus assay as a novel biomarker for lung cancer risk.
El-Zein RA; Schabath MB; Etzel CJ; Lopez MS; Franklin JD; Spitz MR
Cancer Res; 2006 Jun; 66(12):6449-56. PubMed ID: 16778224
[TBL] [Abstract][Full Text] [Related]
3. Cytokinesis-blocked micronucleus cytome assay and spectral karyotyping as methods for identifying chromosome damage in a lung cancer case-control population.
Lloyd SM; Lopez M; El-Zein R
Genes Chromosomes Cancer; 2013 Jul; 52(7):694-707. PubMed ID: 23630028
[TBL] [Abstract][Full Text] [Related]
4. The cytokinesis-blocked micronucleus assay as a strong predictor of lung cancer: extension of a lung cancer risk prediction model.
El-Zein RA; Lopez MS; D'Amelio AM; Liu M; Munden RF; Christiani D; Su L; Tejera-Alveraz P; Zhai R; Spitz MR; Etzel CJ
Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2462-70. PubMed ID: 25172871
[TBL] [Abstract][Full Text] [Related]
5. Cytokinesis-blocked micronucleus cytome assay biomarkers identify lung cancer cases amongst smokers.
El-Zein RA; Fenech M; Lopez MS; Spitz MR; Etzel CJ
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1111-9. PubMed ID: 18483333
[TBL] [Abstract][Full Text] [Related]
6. Prediction of lung cancer based on serum biomarkers by gene expression programming methods.
Yu Z; Chen XZ; Cui LH; Si HZ; Lu HJ; Liu SH
Asian Pac J Cancer Prev; 2014; 15(21):9367-73. PubMed ID: 25422226
[TBL] [Abstract][Full Text] [Related]
7. Use of the cytokinesis-blocked micronucleus assay to detect gender differences and genetic instability in a lung cancer case-control study.
McHugh MK; Lopez MS; Ho CH; Spitz MR; Etzel CJ; El-Zein RA
Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):135-45. PubMed ID: 23195992
[TBL] [Abstract][Full Text] [Related]
8. Adaption of the Cytokinesis-Block Micronucleus Cytome Assay for Improved Triage Biodosimetry.
Beinke C; Port M; Riecke A; Ruf CG; Abend M
Radiat Res; 2016 May; 185(5):461-72. PubMed ID: 27092766
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the genotoxicity and cytotoxicity in the general population in Turkey by use of the cytokinesis-block micronucleus cytome assay.
Donmez-Altuntas H; Bitgen N
Mutat Res; 2012 Oct; 748(1-2):1-7. PubMed ID: 22698568
[TBL] [Abstract][Full Text] [Related]
10. Cytokinesis-block micronucleus cytome assays for the determination of genotoxicity and cytotoxicity of cecal water in rats and fecal water in humans.
Benassi B; Leleu R; Bird T; Clifton P; Fenech M
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2676-80. PubMed ID: 18086773
[TBL] [Abstract][Full Text] [Related]
11. Cytokinesis-Block Micronucleus Cytome Assay Evolution into a More Comprehensive Method to Measure Chromosomal Instability.
Fenech M
Genes (Basel); 2020 Oct; 11(10):. PubMed ID: 33076531
[TBL] [Abstract][Full Text] [Related]
12. Cytokinesis Block Micronucleus Cytome (CBMN Cyt) Assay Biomarkers and Their Association With Radiation Sensitivity Phenotype in Prostate Cancer Cases and DNA Repair Gene hOGG1 (C1245G) Polymorphism.
Dhillon VS; Yeoh E; Salisbury C; Butters J; Di Matteo A; Olver I; Fenech M
Environ Mol Mutagen; 2018 Dec; 59(9):813-821. PubMed ID: 30264500
[TBL] [Abstract][Full Text] [Related]
13. The potential for complete automated scoring of the cytokinesis block micronucleus cytome assay using imaging flow cytometry.
Rodrigues MA; Beaton-Green LA; Wilkins RC; Fenech MF
Mutat Res Genet Toxicol Environ Mutagen; 2018 Dec; 836(Pt A):53-64. PubMed ID: 30389163
[TBL] [Abstract][Full Text] [Related]
14. Nuclear anomalies, chromosomal aberrations and proliferation rates in cultured lymphocytes of head and neck cancer patients.
George A; Dey R; Bhuria V; Banerjee S; Ethirajan S; Siluvaimuthu A; Saraswathy R
Asian Pac J Cancer Prev; 2014; 15(3):1119-23. PubMed ID: 24606428
[TBL] [Abstract][Full Text] [Related]
15. Cytokinesis-block micronucleus assay evolves into a "cytome" assay of chromosomal instability, mitotic dysfunction and cell death.
Fenech M
Mutat Res; 2006 Aug; 600(1-2):58-66. PubMed ID: 16822529
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the genotoxicity and cytotoxicity in environmentally exposed human populations to heavy metals using the cytokinesis-block micronucleus cytome assay.
Mesic A; Nefic H
Environ Toxicol; 2015 Nov; 30(11):1331-42. PubMed ID: 24861359
[TBL] [Abstract][Full Text] [Related]
17. Determining the cut-off value of pro-gastrin releasing peptide (ProGRP) in lung cancer according to population characteristics.
Bubanović G; Pavićević R; Franjević A
Coll Antropol; 2008 Dec; 32(4):1155-64. PubMed ID: 19149223
[TBL] [Abstract][Full Text] [Related]
18. Chromosomal DNA damage measured using the cytokinesis-block micronucleus cytome assay is significantly associated with cognitive impairment in South Australians.
Lee SL; Thomas P; Hecker J; Faunt J; Fenech M
Environ Mol Mutagen; 2015 Jan; 56(1):32-40. PubMed ID: 25099033
[TBL] [Abstract][Full Text] [Related]
19. Extracellular amyloid beta 42 causes necrosis, inhibition of nuclear division, and mitotic disruption under both folate deficient and folate replete conditions as measured by the cytokinesis-block micronucleus cytome assay.
Lee SL; Thomas P; Fenech M
Environ Mol Mutagen; 2014 Jan; 55(1):1-14. PubMed ID: 24038346
[TBL] [Abstract][Full Text] [Related]
20. Mass spectrometric identification, characterization and validation of the haptoglobin β-chain protein as a lung cancer serum biomarker.
Ayyub A; Saleem M; Musharraf SG; Naz M; Tariq A; Hashmi N
Mol Med Rep; 2015 Sep; 12(3):3755-3762. PubMed ID: 26005016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
